MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Hologic's 3-D Mammogram Gets FDA Panel's Blessing

In a 12-0 vote, an FDA panel has found Hologic 's 3-D mammmography device to be safe. The panel stated that the Selenia Dimensions 3-D improves the detection of breast cancer when used with conventional 2-D mammography systems. The combination of 2-D mammography with Hologic's digital mammography tomosynthesis system could reduce recall rates and improve cancer detection.

"The system is designed to increase accuracy when screening women for the presence of cancerous tissue, and to enable a more precise characterization of suspicious lesions," says Jay A. Stein, cofounder and chief technical officer of Hologic. "I speak for all of Hologic in voicing great satisfaction that the FDA panel has weighed in so positively in favor of this valuable new tool in the battle to limit breast cancer mortality."

Selenia Dimensions is currently approved in countries in Europe, Latin America, and Asia, and is used in Canada and Mexico. The device is available in the United States as a 2-D system but would be upgraded to 3-D imaging if or when FDA approved.

 

500 characters remaining